BIOMAT Database Logo BIOMAT Database Logo

Pathways to personalized treatment strategies for depressive disorders. 2015

Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Department of Neurogenetics, Max Planck Institute for Experimental Medicine, Hermann-Rein-Straße 3, 37075, Göttingen, Germany.

UI MeSH Term Description Entries
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Personalized Diagnosis and Treatment for Neuroimaging in Depressive Disorders.
August 2022, Journal of personalized medicine,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
[Diagnostic and treatment strategies for depressive disorders in alcohol dependence].
March 1999, Fortschritte der Neurologie-Psychiatrie,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Treatment for Anxiety and Comorbid Depressive Disorders: Transdiagnostic Cognitive-Behavioral Strategies.
August 2021, Psychiatric annals,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
September 2017, The EPMA journal,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders.
February 2021, Journal of personalized medicine,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Assessment and treatment strategies for depressive disorders commonly encountered in primary care settings.
June 1992, The Nurse practitioner,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Personalized strategies in reproductive medicine for patients with endocrine disorders.
April 2018, Terapevticheskii arkhiv,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Personalized Medicine: Advanced Treatment Strategies to Revolutionize Healthcare.
January 2023, Current drug research reviews,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Sex steroid hormones in depressive disorders as a basis for new potential treatment strategies.
December 2022, Physiological research,
Dorota M Badowska, and Daniela Reich-Erkelenz, and Andrea Schmitt, and Peter Falkai
Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.
September 2018, The EPMA journal,
Copied contents to your clipboard!